Diagnostics in Immunological, Allergic and Inflammatory Disorders
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 6462
Special Issue Editors
Interests: neurodegeneration; cerebral venous outflow; cerebrospinal venous insufficiency; mechanical thrombectomy
Special Issues, Collections and Topics in MDPI journals
Interests: urticaria; angioedema; allergic diseases; asthma
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue entitled “Diagnostics in Immunological, Allergic and Inflammatory Disorders” focuses on recent advances in diagnosing the dysfunctions of the immune system. These pathologies comprising, among others, autoimmune, immunodeficiency and autoinflammatory syndromes, allergic diseases, and inflammatory disorders, represent a considerable burden on individuals and societies alike.
In most people, a wide array of immune abnormalities can be found, not necessarily of clinical relevance, still representing the real diagnostic challenge. Some of these disorders, however, can be life-threatening and should be diagnosed early to enable effective treatment. Unfortunately, for the time being, proper diagnosis cannot always be achieved easily, and thus, novel approaches to the diagnostics of the immune system diseases are warranted.
This Special Issue aims to focus on topics dealing with the diagnostic challenges of these disorders and syndromes. Both original research articles and reviews are welcome.
Dr. Marian Simka
Prof. Dr. Zenon Brzoza
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diagnostics
- allergic diseases
- autoimmune, immunodeficiency and autoinflammatory syndromes
- inflammatory disorders
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.